[시장보고서]조제 약국 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

조제 약국 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Compounding Pharmacies Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1660915

리서치사 : Persistence Market Research

발행일 : 2025년 02월

페이지 정보 : 영문 245 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 6,990,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,208,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 11,887,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 조제 약국 시장 규모는 2025년에 114억 달러로 2025-2032년 예측 기간 동안 5.2%의 CAGR로 확대되어 2032년에는 163억 달러에 달할 것으로 예상됩니다.

조제 약국은 환자의 특정 요구에 맞는 맞춤형 의약품을 만드는 것을 전문으로 하며, 대체 제형, 알레르겐이 없는 의약품 또는 시판되지 않는 의약품의 조합을 필요로 하는 개인을 위한 솔루션을 제공합니다. 이들 약국은 병원, 전문 클리닉, 장기요양시설, 개인 환자를 대상으로 외용 크림, 주사제, 경구용 액제, 소아용 약품 등 다양한 제형을 제공합니다. 시장 성장의 원동력은 맞춤형 의료에 대한 수요 증가, 의약품 부족 심화, 특수한 치료를 필요로 하는 만성질환의 확산입니다.

세계 조제 약국 시장은 환자별 맞춤 의료에 대한 선호도가 높아짐에 따라 몇 가지 중요한 요인에 의해 주도되고 있습니다. 암, 심혈관질환, 호르몬 불균형과 같은 만성질환의 발병률이 증가함에 따라 맞춤형 의약품에 대한 수요가 증가하고 있습니다. 또한, 노인 인구의 증가로 인해 투여가 용이한 대체 제제가 요구되고 있습니다. 조제 약국에 대한 규제 지원과 무균 조제 및 약물 배합 자동화와 같은 약물 배합 기술의 발전은 시장 확대를 더욱 촉진하고 있습니다. 또한, 특정 필수 의약품의 부족으로 인해 특히 병원 및 전문 의료 현장에서 배합 의약품에 대한 의존도가 높아지고 있습니다.

조제 약국 시장은 헬스케어 지출 증가, 조제 기술 발전, 맞춤형 의약품에 대한 인식 증가 등을 배경으로 큰 성장 기회를 제공하고 있습니다. 재택의료 서비스 및 원격의료 플랫폼의 확대로 환자들은 조제 의약품을 편리하게 이용할 수 있게 되었습니다. 또한 3D 약물 인쇄, 나노기술 기반 제형, 약물 맞춤화에서 인공지능의 통합 등 조제 기술의 혁신은 시장 진입 기업에게 새로운 길을 열어주고 있습니다. R&D에 대한 투자와 함께 조제 약국 및 의료 서비스 제공자와의 전략적 파트너십은 새로운 기회를 활용하고 진화하는 이 산업에서 시장 리더십을 유지하는 데 매우 중요합니다.

세계의 조제 약국 시장에 대해 조사했으며, 제품별, 용도별, 치료 분야별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 전해드립니다.

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for compounding pharmacies. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global compounding pharmacies market from 2025 to 2032.

Key Insights:

Compounding Pharmacies Market Size (2025E):USD 11.4 Billion
Projected Market Value (2032F): USD 16.3 Billion
Global Market Growth Rate (CAGR 2025 to 2032): 5.2%

Compounding Pharmacies Market - Report Scope:

Compounding pharmacies specialize in creating customized medications tailored to the specific needs of patients, offering solutions for individuals who require alternative dosage forms, allergen-free medications, or drug combinations not commercially available. These pharmacies cater to hospitals, specialty clinics, long-term care facilities, and individual patients, providing compounded formulations such as topical creams, injectables, oral liquids, and pediatric dosages. Market growth is driven by the rising demand for personalized medicine, increasing drug shortages, and the growing prevalence of chronic diseases requiring specialized treatments.

Market Growth Drivers:

The global compounding pharmacies market is propelled by several key factors, including the rising preference for personalized medicine to address unique patient needs. The increasing incidence of chronic illnesses, such as cancer, cardiovascular diseases, and hormonal imbalances, has heightened demand for customized medications. Additionally, the growing geriatric population requires alternative drug formulations suited for ease of administration. Regulatory support for compounding pharmacies and advancements in pharmaceutical compounding techniques, such as sterile compounding and automation in drug formulation, further boost market expansion. The shortage of certain essential drugs has also led to an increased reliance on compounded medications, particularly in hospital and specialty care settings.

Market Restraints:

Despite promising growth prospects, the compounding pharmacies market faces challenges related to stringent regulatory requirements, concerns over product quality and safety, and high operational costs. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), impose strict guidelines on compounding practices to ensure patient safety. Compliance with these regulations increases costs for pharmacies, particularly for small-scale operators. Additionally, the risk of contamination and variability in drug potency can affect consumer trust and regulatory approvals. The increasing availability of generic and specialty drugs in the commercial market also poses a challenge to the demand for compounded medications.

Market Opportunities:

The compounding pharmacies market presents significant growth opportunities driven by increasing healthcare expenditure, technological advancements in drug compounding, and growing awareness about customized medications. The expansion of home healthcare services and telemedicine platforms allows patients to access compounded medications conveniently. Moreover, innovations in compounding techniques, including 3D drug printing, nanotechnology-based formulations, and the integration of artificial intelligence in medication customization, open new avenues for market players. Strategic partnerships between compounding pharmacies and healthcare providers, along with investments in R&D, will be crucial in capitalizing on emerging opportunities and sustaining market leadership in this evolving industry.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the compounding pharmacies market globally?
Which compounding formulations and applications are witnessing increased demand across different healthcare settings?
How are regulatory policies shaping the competitive landscape of the compounding pharmacies market?
Who are the key players contributing to the compounding pharmacies market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global compounding pharmacies market?

Competitive Intelligence and Business Strategy:

Leading players in the global compounding pharmacies market, including B. Braun Medical Inc., Fagron, Inc., and PharMEDium Services LLC, focus on innovation, quality assurance, and regulatory compliance to gain a competitive edge. These companies invest in R&D to develop advanced compounding solutions, including sterile injectables, hormone replacement therapies, and veterinary compounded medications. Collaborations with hospitals, specialty clinics, and regulatory agencies facilitate market access and ensure adherence to stringent pharmaceutical standards. Additionally, emphasis on automation in compounding processes, training for pharmacists, and consumer education fosters market growth and enhances patient confidence in customized medications.

Key Companies Profiled:

B. Braun Medical Inc.
Fagron, Inc.
PharMEDium Services LLC
Pencol Compounding Pharmacy
Wedgewood Pharmacy
Specialty Compounding LLC
Bellevue Pharmacy
McGuff Compounding Pharmacy Services, Inc.
Rx3 Compounding Pharmacy
MEDISCA

Key Segments Covered in Compounding Pharmacies Industry Research

Product:

Oral Medication
Topical Medications
Mouthwashes
Suppositories

Application:

Medication for Adults
Medication for Veterinary
Medication for Children
Medication for Geriatric

Therapeutic Area:

Pain Management
Hormone Replacement Therapy

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Recent Product Approvals/ Launches
4.3. Key Promotional Strategies, By Manufacturers
4.4. Supply Chain Analysis
4.5. Porter's Five Forces Analysis
4.6. PESTEL Analysis
4.7. Regulatory Dynamics

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure Overview
- 5.1.3. Global Personalized Medicine Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Rising geriatric population
- 5.2.2. Increasing oral medications
- 5.2.3. Growing public adoption of hormone replacement therapy (HRTs)
- 5.2.4. Increasing medicine scarcity
- 5.2.5. Rising pharmaceutical R&D
- 5.2.6. Rise in pet adoption
- 5.2.7. Strategic collaborations
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. Revenue By Product
- 6.1.2. Revenue By Application
- 6.1.3. Revenue By Therapeutic Area
- 6.1.4. Revenue By Country
6.2. 2022 Market Scenario

7. Global Compounding Pharmacies Market Demand (Size in US$ Bn) Analysis, 2019 - 2032

7.1. Historical Market Value (US$ Bn) Analysis, 2019 - 2024
7.2. Current and Future Market Value (US$ Bn) Projections, 2025 - 2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Compounding Pharmacies Market Analysis 2019 - 2032, By Product

8.1. Introduction / Key Findings
8.2. Historical Market Size (In Value or Size in US$ Bn) Trend By Product, 2019 - 2024
8.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Product, 2025 - 2032
- 8.3.1. Oral Medications
  - 8.3.1.1. Capsules
  - 8.3.1.2. Tablets
  - 8.3.1.3. Mixtures
  - 8.3.1.4. Lollipops
  - 8.3.1.5. Lozenges
- 8.3.2. Topical Medications
  - 8.3.2.1. Gels
  - 8.3.2.2. Ointments
  - 8.3.2.3. Creams
  - 8.3.2.4. Lotions
- 8.3.3. Mouthwashes
- 8.3.4. Suppositories
8.4. Market Attractiveness Analysis By Product

9. Global Compounding Pharmacies Market Analysis 2019 - 2032, By Application

9.1. Introduction / Key Findings
9.2. Historical Market Size (In Value or Size in US$ Bn) Trend By Application, 2019 - 2024
9.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Application, 2025 - 2032
- 9.3.1. Medication for Adults
- 9.3.2. Medication for Veterinary
- 9.3.3. Medication for Children
- 9.3.4. Medication for Geriatric
9.4. Market Attractiveness Analysis By Application

10. Global Compounding Pharmacies Market Analysis 2019 - 2032, By Therapeutic Area

10.1. Introduction / Key Findings
10.2. Historical Market Size (In Value or Size in US$ Bn) Trend By Therapeutic Area, 2019 - 2024
10.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Therapeutic Area, 2025 - 2032
- 10.3.1. Pain Management
- 10.3.2. Hormone Replacement Therapy
10.4. Market Attractiveness Analysis By Therapeutic Area

11. Global Compounding Pharmacies Market Analysis 2019 - 2032, by Region

11.1. Introduction
11.2. Historical Market Size (In Value or Size in US$ Bn) Analysis By Region, 2019 - 2024
11.3. Current Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Region, 2025 - 2032
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. South Asia
- 11.3.5. East Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region

12. North America Compounding Pharmacies Market Analysis 2019 - 2032

12.1. Introduction
12.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
12.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Product
- 12.3.3. By Application
- 12.3.4. By Therapeutic Area
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product
- 12.4.3. By Application
- 12.4.4. By Therapeutic Area
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
- 12.8.1. U.S. Compounding Pharmacies Market Analysis
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.1.2.1. By Product
    - 12.8.1.2.2. By Application
    - 12.8.1.2.3. By Therapeutic Area
- 12.8.2. Canada Compounding Pharmacies Market Analysis
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.2.2.1. By Product
    - 12.8.2.2.2. By Application
    - 12.8.2.2.3. By Therapeutic Area

13. Latin America Compounding Pharmacies Market 2019 - 2032

13.1. Introduction
13.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
13.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 13.3.1. By Country
  - 13.3.1.1. Brazil
  - 13.3.1.2. Mexico
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
- 13.3.2. By Product
- 13.3.3. By Application
- 13.3.4. By Therapeutic Area
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product
- 13.4.3. By Application
- 13.4.4. By Therapeutic Area
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. Brazil Compounding Pharmacies Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Product
    - 13.8.1.2.2. By Application
    - 13.8.1.2.3. By Therapeutic Area
- 13.8.2. Mexico Compounding Pharmacies Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Product
    - 13.8.2.2.2. By Application
    - 13.8.2.2.3. By Therapeutic Area
- 13.8.3. Argentina Compounding Pharmacies Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.3.2.1. By Product
    - 13.8.3.2.2. By Application
    - 13.8.3.2.3. By Therapeutic Area

14. Europe Compounding Pharmacies Market Analysis, 2019 - 2032

14.1. Introduction
14.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
14.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. UK
  - 14.3.1.3. France
  - 14.3.1.4. Italy
  - 14.3.1.5. Russia
  - 14.3.1.6. Spain
  - 14.3.1.7. BENELUX
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Product
- 14.3.3. By Application
- 14.3.4. By Therapeutic Area
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product
- 14.4.3. By Application
- 14.4.4. By Therapeutic Area
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Germany Compounding Pharmacies Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Product
    - 14.8.1.2.2. By Application
    - 14.8.1.2.3. By Therapeutic Area
- 14.8.2. UK Compounding Pharmacies Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Product
    - 14.8.2.2.2. By Application
    - 14.8.2.2.3. By Therapeutic Area
- 14.8.3. Russia Compounding Pharmacies Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Product
    - 14.8.3.2.2. By Application
    - 14.8.3.2.3. By Therapeutic Area
- 14.8.4. Spain Compounding Pharmacies Market Analysis
  - 14.8.4.1. Introduction
  - 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.4.2.1. By Product
    - 14.8.4.2.2. By Application
    - 14.8.4.2.3. By Therapeutic Area
- 14.8.5. France Compounding Pharmacies Market Analysis
  - 14.8.5.1. Introduction
  - 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.5.2.1. By Product
    - 14.8.5.2.2. By Application
    - 14.8.5.2.3. By Therapeutic Area
- 14.8.6. Italy Compounding Pharmacies Market Analysis
  - 14.8.6.1. Introduction
  - 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.6.2.1. By Product
    - 14.8.6.2.2. By Application
    - 14.8.6.2.3. By Therapeutic Area
- 14.8.7. BENELUX Compounding Pharmacies Market Analysis
  - 14.8.7.1. Introduction
  - 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.7.2.1. By Product
    - 14.8.7.2.2. By Application
    - 14.8.7.2.3. By Therapeutic Area

15. South Asia Compounding Pharmacies Market Analysis, 2019 - 2032

15.1. Introduction
15.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
15.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 15.3.1. By Country
  - 15.3.1.1. India
  - 15.3.1.2. Indonesia
  - 15.3.1.3. Malaysia
  - 15.3.1.4. Thailand
  - 15.3.1.5. Rest of South Asia
- 15.3.2. By Product
- 15.3.3. By Application
- 15.3.4. By Therapeutic Area
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product
- 15.4.3. By Application
- 15.4.4. By Therapeutic Area
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. India Compounding Pharmacies Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Product
    - 15.8.1.2.2. By Application
    - 15.8.1.2.3. By Therapeutic Area
- 15.8.2. Indonesia Compounding Pharmacies Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Product
    - 15.8.2.2.2. By Application
    - 15.8.2.2.3. By Therapeutic Area
- 15.8.3. Malaysia Compounding Pharmacies Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Product
    - 15.8.3.2.2. By Application
    - 15.8.3.2.3. By Therapeutic Area
- 15.8.4. Thailand Compounding Pharmacies Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.4.2.1. By Product
    - 15.8.4.2.2. By Application
    - 15.8.4.2.3. By Therapeutic Area

16. East Asia Compounding Pharmacies Market Analysis, 2019 - 2032

16.1. Introduction
16.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
16.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 16.3.1. By Country
  - 16.3.1.1. China
  - 16.3.1.2. Japan
  - 16.3.1.3. South Korea
- 16.3.2. By Product
- 16.3.3. By Application
- 16.3.4. By Therapeutic Area
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product
- 16.4.3. By Application
- 16.4.4. By Therapeutic Area
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. China Compounding Pharmacies Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Product
    - 16.8.1.2.2. By Application
    - 16.8.1.2.3. By Therapeutic Area
- 16.8.2. Japan Compounding Pharmacies Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Product
    - 16.8.2.2.2. By Application
    - 16.8.2.2.3. By Therapeutic Area
- 16.8.3. South Korea Compounding Pharmacies Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Product
    - 16.8.3.2.2. By Application
    - 16.8.3.2.3. By Therapeutic Area

17. Oceania Compounding Pharmacies Market Analysis, 2019 - 2032

17.1. Introduction
17.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
17.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Product
- 17.3.3. By Application
- 17.3.4. By Therapeutic Area
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product
- 17.4.3. By Application
- 17.4.4. By Therapeutic Area
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. Australia Compounding Pharmacies Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Product
    - 17.8.1.2.2. By Application
    - 17.8.1.2.3. By Therapeutic Area
- 17.8.2. New Zealand Compounding Pharmacies Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Product
    - 17.8.2.2.2. By Application
    - 17.8.2.2.3. By Therapeutic Area

18. Middle East & Africa (MEA) Compounding Pharmacies Market Analysis, 2019 - 2032

18.1. Introduction
18.2. Historical Market Size (In Value or Size in US$ Bn) Trend Analysis By Market Taxonomy, 2019 - 2024
18.3. Current and Future Market Size (In Value or Size in US$ Bn) Analysis and Forecast By Market Taxonomy, 2025 - 2032
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkey
  - 18.3.1.3. South Africa
  - 18.3.1.4. North Africa
  - 18.3.1.5. Rest of MEA
- 18.3.2. By Product
- 18.3.3. By Application
- 18.3.4. By Therapeutic Area
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Product
- 18.4.3. By Application
- 18.4.4. By Therapeutic Area
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. GCC Countries Compounding Pharmacies Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Product
    - 18.8.1.2.2. By Application
    - 18.8.1.2.3. By Therapeutic Area
- 18.8.2. Turkey Compounding Pharmacies Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Product/p>
    - 18.8.2.2.2. By Application
    - 18.8.2.2.3. By Therapeutic Area
- 18.8.3. South Africa Compounding Pharmacies Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.3.2.1. By Product
    - 18.8.3.2.2. By Application
    - 18.8.3.2.3. By Therapeutic Area
- 18.8.4. North Africa Compounding Pharmacies Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.4.2.1. By Product
    - 18.8.4.2.2. By Application
    - 18.8.4.2.3. By Therapeutic Area

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
- 19.4.1. Regional footprint of Players
- 19.4.2. Product foot print by Players
- 19.4.3. Channel Foot Print by Players

20. Competition Analysis

20.1. Competition Dashboard
20.2. Competition Deep Dive
- 20.2.1. Fagron
  - 20.2.1.1. Overview
  - 20.2.1.2. Product Portfolio
  - 20.2.1.3. Key Financials
  - 20.2.1.4. Sales Footprint
  - 20.2.1.5. SWOT Analysis
  - 20.2.1.6. Strategy Overview
    - 20.2.1.6.1. Marketing Strategy
    - 20.2.1.6.2. Product Strategy
    - 20.2.1.6.3. Channel Strategy
- 20.2.2. Fresenius Kabi AG
  - 20.2.2.1. Overview
  - 20.2.2.2. Product Portfolio
  - 20.2.2.3. Key Financials
  - 20.2.2.4. Sales Footprint
  - 20.2.2.5. SWOT Analysis
  - 20.2.2.6. Strategy Overview
    - 20.2.2.6.1. Marketing Strategy
    - 20.2.2.6.2. Product Strategy
    - 20.2.2.6.3. Channel Strategy
- 20.2.3. PharMEDium Services, LLC,
  - 20.2.3.1. Overview
  - 20.2.3.2. Product Portfolio
  - 20.2.3.3. Key Financials
  - 20.2.3.4. Sales Footprint
  - 20.2.3.5. SWOT Analysis
  - 20.2.3.6. Strategy Overview
    - 20.2.3.6.1. Marketing Strategy
    - 20.2.3.6.2. Product Strategy
    - 20.2.3.6.3. Channel Strategy
- 20.2.4. Institutional Pharmacy Solutions
  - 20.2.4.1. Overview
  - 20.2.4.2. Product Portfolio
  - 20.2.4.3. Key Financials
  - 20.2.4.4. Sales Footprint
  - 20.2.4.5. SWOT Analysis
  - 20.2.4.6. Strategy Overview
    - 20.2.4.6.1. Marketing Strategy
    - 20.2.4.6.2. Product Strategy
    - 20.2.4.6.3. Channel Strategy
- 20.2.5. Cantrell Drug Company
  - 20.2.5.1. Overview
  - 20.2.5.2. Product Portfolio
  - 20.2.5.3. Key Financials
  - 20.2.5.4. Sales Footprint
  - 20.2.5.5. SWOT Analysis
  - 20.2.5.6. Strategy Overview
    - 20.2.5.6.1. Marketing Strategy
    - 20.2.5.6.2. Product Strategy
    - 20.2.5.6.3. Channel Strategy
- 20.2.6. Lorraine's Pharmacy
  - 20.2.6.1. Overview
  - 20.2.6.2. Product Portfolio
  - 20.2.6.3. Key Financials
  - 20.2.6.4. Sales Footprint
  - 20.2.6.5. SWOT Analysis
  - 20.2.6.6. Strategy Overview
    - 20.2.6.6.1. Marketing Strategy
    - 20.2.6.6.2. Product Strategy
    - 20.2.6.6.3. Channel Strategy
- 20.2.7. B. Braun Melsungen AG Company
  - 20.2.7.1. Overview
  - 20.2.7.2. Product Portfolio
  - 20.2.7.3. Key Financials
  - 20.2.7.4. Sales Footprint
  - 20.2.7.5. SWOT Analysis
  - 20.2.7.6. Strategy Overview
    - 20.2.7.6.1. Marketing Strategy
    - 20.2.7.6.2. Product Strategy
    - 20.2.7.6.3. Channel Strategy

한글목차

목차

제1장 주요 요약

제2장 시장 개요

제3장 주요 시장 동향

제4장 핵심성공요인

제5장 시장 배경

제6장 COVID-19 위기 분석

제7장 세계의 조제 약국 시장 수요(규모, 10억 달러) 분석, 2019-2032년

제8장 세계의 조제 약국 시장 분석, 2019-2032년, 제품별

제9장 세계의 조제 약국 시장 분석, 2019-2032년, 용도별

제10장 세계의 조제 약국 시장 분석, 2019-2032년, 치료 분야별

제11장 세계의 조제 약국 시장 분석, 2019-2032년, 지역별

제12장 북미의 조제 약국 시장 분석, 2019-2032년

제13장 라틴아메리카의 조제 약국 시장 2019-2032년

제14장 유럽의 조제 약국 시장 분석, 2019-2032년

제15장 남아시아의 조제 약국 시장 분석, 2019-2032년

제16장 동아시아의 조제 약국 시장 분석, 2019-2032년

제17장 오세아니아의 조제 약국 시장 분석, 2019-2032년

제18장 중동 및 아프리카의 조제 약국 시장 분석, 2019-2032년

제19장 시장 구조 분석

제20장 경쟁 분석

제21장 사용되는 가정과 두문자어

제22장 조사 방법